Two Sigma Advisers’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-20,500
Closed -$13.5K 2822
2022
Q4
$13.5K Sell
20,500
-5,100
-20% -$2.69K ﹤0.01% 2448
2022
Q3
$12K Sell
25,600
-11,900
-32% -$6.17K ﹤0.01% 2475
2022
Q2
$19K Sell
37,500
-12,600
-25% -$6.17K ﹤0.01% 2556
2022
Q1
$26K Sell
50,100
-14,700
-23% -$8.53K ﹤0.01% 2649
2021
Q4
$41K Sell
64,800
-23,500
-27% -$26.5K ﹤0.01% 2489
2021
Q3
$134K Sell
88,300
-99,600
-53% -$162K ﹤0.01% 2301
2021
Q2
$321K Buy
187,900
+2,000
+1% +$3.45K ﹤0.01% 2114
2021
Q1
$316K Sell
185,900
-55,600
-23% -$124K ﹤0.01% 2202
2020
Q4
$413K Buy
241,500
+20,900
+9% +$20.8K ﹤0.01% 1937
2020
Q3
$162K Buy
220,600
+73,500
+50% +$58.2K ﹤0.01% 2200
2020
Q2
$123K Buy
147,100
+12,800
+10% +$6.55K ﹤0.01% 2338
2020
Q1
$36K Sell
134,300
-9,000
-6% -$3.58K ﹤0.01% 2394
2019
Q4
$71K Buy
143,300
+49,900
+53% +$30.6K ﹤0.01% 2274
2019
Q3
$101K Buy
+93,400
New +$195K ﹤0.01% 2113

Other funds holding TMDI

Two Sigma Advisers's TMDI Position: Q1 2023 in Review

Two Sigma Advisers sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q1 2023, closing a stake of 20,500 shares — an estimated $13.5K sold.

Two Sigma Advisers first reported a position in TMDI in Q3 2019 and held it in 14 quarters. The position peaked at $413K in Q4 2020. 12 funds tracked by Wall St. Rank hold TMDI as of Q1 2023.

  • Two Sigma Advisers reported no remaining Titan Medical Inc. Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 20,500 Titan Medical Inc. Ordinary Shares shares in Q1 2023, an estimated $13.5K.
  • Two Sigma Advisers first reported a position in Titan Medical Inc. Ordinary Shares in Q3 2019 and held it in 14 quarters.
  • Two Sigma Advisers's Titan Medical Inc. Ordinary Shares position peaked at $413K in Q4 2020.
  • 12 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q1 2023.

Based on Two Sigma Advisers's 13F filing for Q1 2023, filed 15 May 2023.